Live Breaking News & Updates on Meibomian gland disease

Stay updated with breaking news from Meibomian gland disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tarsus Announces Positive Topline Results from Carpo, a Phase 2a Proof-of-Concept "Tick-Kill" Trial Evaluating TP-05 (lotilaner) for the Prevention of Lyme Disease -February 22, 2024 at 08:03 am EST

TP-05 demonstrated tolerability and statistically significant tick mortality, suggesting potential for on-demand Lyme disease prophylaxisIRVINE, Calif., Feb. 22, 2024 -- Tarsus Pharmaceuticals,...

United-states , Americans , Adrienne-kemp , David-nakasone , Centers-for-disease , Exchange-commission , Corporate-communications , Tarsus-pharmaceuticals-inc , Nasdaq , Disease-control , Tarsus-pharmaceuticals , Meibomian-gland-disease

Tarsus to Report Fourth Quarter and Full Year 2023 Financial Results on Tuesday, February 27, 2024

IRVINE, Calif., Feb. 20, 2024 -- Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,...

United-states , David-nakasone , Adrienne-kemp , Nasdaq , Corporate-communications , Tarsus-pharmaceuticals-inc , Tarsus-pharmaceuticals , Meibomian-gland-disease , Markets ,

Tarsus to Participate in Fireside Chat at the Sixth Annual Guggenheim Healthcare Talks Conference

Tarsus to Participate in Fireside Chat at the Sixth Annual Guggenheim Healthcare Talks Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , David-nakasone , Adrienne-kemp , Bobak-azamian , Corporate-communications , Tarsus-pharmaceuticals-inc , Nasdaq , Chief-executive-officer , Sixth-annual-guggenheim-healthcare-talks , New-york-city , Tarsus-pharmaceuticals

The Scratchy, Gritty, Misery of Dry Eye Disease

The Scratchy, Gritty, Misery of Dry Eye Disease
theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.

United-states , United-kingdom , Australia , British , Australian , American , Americans , Christophe-baudouin , Lauram-periman , Vectormine-shutterstock , United-states-health-care-system , American-journal

Tarsus Pharmaceuticals, Inc. Announces Positive Topline Results from the Ersa Phase 2A Clinical Trial Evaluating Tp-03 for the Treatment of Meibomian Gland Disease in Patients with Demodex Mites

Tarsus Pharmaceuticals, Inc. announced topline results from the Ersa Phase 2a clinical trial evaluating TP-03 administered twice daily or three times a day for 12 weeks for the treatment of Meibomian...

United-states , Drug-administration , Tarsus-pharmaceuticals-inc , Tarsus-pharmaceuticals , Ersa-phase , Meibomian-gland-disease , Meibomian-gland-secretion-score , Gland-disease , Markets ,

Tarsus: TP-03 Phase 2a Clinical Trial Shows Positive Data In MGD In Patients With Demodex Mites

Tarsus Pharmaceuticals, Inc. (TARS) announced Monday positive topline results from the Ersa Phase 2a clinical trial evaluating TP-03 (lotilaner ophthalmic solution, 0.

Bobak-azamian , Tarsus-pharmaceuticals-inc , Drug-administration , More-such-health-news , Tarsus-pharmaceuticals , Ersa-phase , Meibomian-gland-disease , Meibomian-gland-secretion-score , Chief-executive-officer , Tarsus , Ep-03

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q3 2023 Earnings Call Transcript

Operator: Good afternoon and welcome to the Tarsus Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. As a reminder, this call is being recorded.

United-states , Americans , American , America , David-nakasone , William-blair , Bobak-azamian , Jason-gerberry , Jeff-farrow , Bobby-azamian , Aziz-mottiwala , Tim-lugo

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q3 2023 Earnings Call Transcript

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q3 2023 Earnings Call Transcript November 10, 2023 Operator: Good afternoon and welcome to the Tarsus Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to David Nakasone, Head of Investor Relations to […]

United-states , American , Bobak-azamian , Jeff-farrow , American-academy-of-ophthalmology , Biggest-geothermal-companies , American-academy , Optometry-conferences , Meibomian-gland-disease , Ken-fisher-top-dividend ,

Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Adrienne-kempsr , Tarsus-pharmaceuticals-inc , Nasdaq , Corporate-communications , Tarsus-pharmaceuticals , Inc-tarsus-pharmaceuticals , Meibomian-gland-disease , Media-contact , David-nakasonehead , Investor-relations ,

Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United-states , Adrienne-kemp , David-nakasone , Tarsus-pharmaceuticals-inc , Nasdaq , Corporate-communications , Tarsus-pharmaceuticals , Meibomian-gland-disease ,